(Q40527084)

21 September 2017

Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells (English)

1 reference

21 September 2017

Zoltan Wiener

1

1 reference

21 September 2017

Edgar C Ontsouka

2

1 reference

21 September 2017

Sabine Jakob

3

1 reference

21 September 2017

Ralph Torgler

4

1 reference

21 September 2017

Andras Falus

5

1 reference

21 September 2017

Christoph Mueller

6

1 reference

21 September 2017

Thomas Brunner

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Experimental Cell Research

21 September 2017

1 reference

21 September 2017

299

1 reference

21 September 2017

1

1 reference

21 September 2017

227-235

1 reference

21 September 2017

Myc and the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

The role of c-myc in cellular growth control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Translocations involving c-myc and c-myc function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Induction of apoptosis in fibroblasts by c-myc protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Expression of Fas ligand in activated T cells is regulated by c-Myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

A 'non-canonical' DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Tumor expression of Fas ligand (CD95L) and the consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

The Fas counterattack: cancer as a site of immune privilege

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Amplification of the c-myc oncogene in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Oncogenic activity of the c-Myc protein requires dimerization with Max.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Signaling and transcriptional control of Fas ligand gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

7 January 2021

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Regulation of the proinflammatory effects of Fas ligand (CD95L).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Antitumor effect of locally produced CD95 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Immune privilege or inflammation? Insights into the Fas ligand enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

The Myc/Max/Mad network and the transcriptional control of cell behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

The Max network gone mad.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

Phorbol ester-induced expression of airway squamous cell differentiation marker, SPRR1B, is regulated by protein kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.031

10.1016/J.YEXCR.2004.05.031

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference